Skip to main content

Advertisement

Log in

The association between pulmonary function impairment and colon inflammation in ulcerative colitis patients: A scientific basis for exterior-interior correlation between lung and large intestine

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigated the involvement of pulmonary function impairment in ulcerative colitis (UC), to explore a scientific basis for the Chinese medicine (CM) theory of exterior-interior correlation between Lung (Fei) and Large intestine (Dachang).

Methods

Totally 120 patients with a diagnosis of UC were recruited and the demographics, clinical data, and blood samples were collected. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) concentrations were measured. Every patient accepted pulmonary function test and took chest radiograph (CXR).>

Results

Pulmonary function abnormalities were present in 72 of 120 patients. The median (interquartile range) vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), carbon monoxide diffusion capacity (DLCO) of lung, total lung capacity (TLC) and functional residual volume (FRV) were decreased in distal UC and pancolitis compared with ulcerative prochitis (P <0.0005). Male patients had increased VC, FEV1/FVC, and residual volume (RV)/TLC compared with female (P <0.0005), but decreased DLCO and carbon monoxide iffusion capacity (KCO) of lung/alveolar ventilation (P <0.0005). Age was strongly correlated with RV (Spearman rank correlation coefficient (rs)=−0.57,P <0.0001), and RV/TLC (rs=0.48,P<0.0001). Age was also correlated with FEV1/FVC (rs=−0.29, P=0.001), forced expiratory flow in 75% vital capacity (FEF75%, rs=−0.20, P=0.03), DLCO (rs=−0.21, P=0.02), TLC (rs=−0.25, P=0.006), and FRV (rs=−0.28, P=0.002). The course of disease was correlated with FEF75% (rs=−0.18, P=0.049) and KCO (rs=−0.19, P=0.036). Chest radiograph abnormalities were presented in 38 of 120. Pulmonary symptoms were presented in 10 of 120. Other extraintestinal complications were presented in 21 of 120.

Conclusions

Pulmonary function impairment was more frequently than other extraintestinal complications in UC patients, which may be affected by sex, age, extent and course of disease. These results may be a scientific basis for the theory of exterior-interior correlation between Lung and Large intestine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cooperative Group of Inflammatory Bowel Disease Chinese Society of Digestive Disease, Chinese Medical Association. Consensus on diagnosis and treatment program of inflammatory bowel disease in China (2007, Jinan). Chin J Dig (Chin) 2007;27:545–550.

    Google Scholar 

  2. Baumgart DC. The diagnosis and treatment of Crohn’s disease and ulcerative colitis. Dtsch Arztebl Int 2009;106:123–133.

    PubMed  PubMed Central  Google Scholar 

  3. Davies D, MacFarlane A. Fibrosing alveolitis and treatment with sulphasalazine. Gut 1974;15:185–188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454–459.

    Article  CAS  PubMed  Google Scholar 

  5. Douglas JG, McDonald CF, Leslie MJ, Gillon J, Crompton GK, McHardy GJ. Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? Respir Med 1989;83:389–394.

    Article  CAS  PubMed  Google Scholar 

  6. Ceyhan BB, Karakurt S, Cevik H, Sungur M. Bronchial hyperreactivity and allergic status in inflammatory bowel disease. Respiration 2003;70:60–66.

    Article  PubMed  Google Scholar 

  7. Karadag F, Ozhan MH, Akcicek E, Günel O, Alper H, Veral A. Is it possible to detect ulcerative colitis-related respiratory syndrome early? Respirology 2001;6:341–346.

    Article  CAS  PubMed  Google Scholar 

  8. Louis E, Louis R, Drion V, Bonnet V, Lamproye A, Radermecker M, et al. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 1995;50:729–733.

    Article  CAS  PubMed  Google Scholar 

  9. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827–836.

    Article  PubMed  Google Scholar 

  10. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007;131:524–532.

    Article  PubMed  Google Scholar 

  11. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yüksel I, Ataseven H, Baçar O, Köklü S, Ertuğrul I, Ulker A, et al. Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 2011;56:183–187.

    Article  PubMed  Google Scholar 

  13. Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 2001;40:1256–1261.

    Article  CAS  PubMed  Google Scholar 

  14. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387–391.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Feliciani C, De Simone C, Amerio P. Dermatological signs during inflammatory bowel diseases. Eur Rev Med Pharmacol Sci 2009;13(Suppl 1):15–21.

    PubMed  Google Scholar 

  16. Cury DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:1393–1396.

    Article  PubMed  Google Scholar 

  17. Yilmaz S, Aydemir E, Maden A, Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis 2007;22:1027–1030.

    Article  PubMed  Google Scholar 

  18. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006;26:31–40.

    Article  PubMed  Google Scholar 

  19. Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:1598–1619.

    Article  PubMed  Google Scholar 

  20. Yılmaz A, Yılmaz Demirci N, Hoşgün D, Uner E, Erdoǧan Y, Gökçek A, et al. Pulmonary involvement in inflammatory bowel disease. World J Gastroenterol 2010;16:4952–4957.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Mohamed-Hussein AA, Mohamed NA, Ibrahim ME. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 2007;101:977–982.

    Article  PubMed  Google Scholar 

  22. Herrlingerkr, Noftzmk, Dalhoffk, Ludwig D, Stange EF, Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002;97:377–381.

    Article  Google Scholar 

  23. Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A. Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung 2008;186:167–172.

    Article  PubMed  Google Scholar 

  24. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7:235–241.

    Google Scholar 

  25. Carvalho RS, Wilson L, Cuffari C. Pulmonary manifestations in a pediatric patient with ulcerative colitis: a case report. J Med Case Rep 2008;2:59.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jing S, Wang XY, Zhu L, Yang X, Zhou B. Discussion on theory of the lung and the large intestine being interiorexteriorly related based on tow UC rat models. China J Tradit Chin Med Pharm (Chin) 2011;26:129–131.

    Google Scholar 

  27. Yang X, Wang XY, Zhu L, Jing S, Zhou B, Yang S. The correlation between VIP level in colon mucosa of rat and the method of “treating intestine from lung”. Chin J Basic Med Tradit Chin Med (Chin) 2011;11:282–283

    Google Scholar 

  28. Sun HY, Wang XY, Wu J, Zhang W, Liu DM, Wang JY. The interior-exterior correlation between Fei and Dachang from the lung function injury in ulcerative colitis patients. Chin J Intergr Med 2011;31:591–594.

    CAS  Google Scholar 

  29. Raj AA, Birring SS, Green R, Grant A, de Caestecker J, Pavord ID. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008;102:780–785.

    Article  CAS  PubMed  Google Scholar 

  30. Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr 2011;52:650–661.

    Article  CAS  PubMed  Google Scholar 

  31. Ozyilmaz E, Yildirim B, Erbas G, Akten S, Akten S, Oguzulgen IK, et al. Value of fractional exhaled nitric oxide (FE NO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease. Inflamm Bowel Dis 2010;16:670–676.

    Article  PubMed  Google Scholar 

  32. Zhu L, Liu YN, Yu RJ. Clinical pulmonary function. Beijing: People’s Medical Publishing House; 2004:133–134.

    Google Scholar 

  33. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779–787.

    Article  PubMed  Google Scholar 

  34. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 2010;42:97–114.

    Article  PubMed  Google Scholar 

  35. Fenta YA, Tello N, Jung JA, Urm SH, Loftus EV Jr, Yawn BP, et al. Inflammatory bowel disease and asthma: a population-based, case-control study. Inflamm Bowel Dis 2010;16:1957–1962.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr 2011;52:650–661.

    Article  CAS  PubMed  Google Scholar 

  37. Hamada S, Ito Y, Imai S, Oguma T, Niimi A, Mishima M. Effect of inhaled corticosteroid therapy on CT scan-estimated airway dimensions in a patient with chronic bronchitis related to ulcerative colitis. Chest 2011;139:930–932.

    Article  PubMed  Google Scholar 

  38. Casella G, Villanacci V, Di Bella C, Antonelli E, Baldini V, Bassotti G. Pulmonary diseases associated with inflammatory bowel diseases. J Crohns Colitis 2010;4:384–389.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

All study design, analysis and manuscript preparation were carried out independently in Dongzhimen Hospital, China. We thank all the clinical staff of Dongzhimen Hospital involved in the care of the patients in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin-yue Wang  (王新月).

Additional information

Supported by the National Basic Research Program, Ministry of Science and Technology, China (No. 2009CB522705)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Jy., Wang, Xy., Wu, Hy. et al. The association between pulmonary function impairment and colon inflammation in ulcerative colitis patients: A scientific basis for exterior-interior correlation between lung and large intestine. Chin. J. Integr. Med. 22, 894–901 (2016). https://doi.org/10.1007/s11655-014-1842-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1842-2

Keywords

Navigation